Latest Intellectual Property News

Entropy Neurodynamics has been granted an Australian patent for its novel two-phase IV infusion method administering psilocybin and psilocin, securing exclusive rights through 2042 and strengthening its lead asset TRP-8803’s competitive position.

Racura Oncology has developed a pioneering blood test that promises to fast-track key data on its cardioprotective drug RC220, potentially shaving two years off the clinical trial timeline. This innovation also enhances patient safety and recruitment prospects in the ongoing RAC-010 CPACS trial.

Critical Resources Limited has launched a six-month evaluation program in partnership with the South Dakota School of Mines & Technology to develop next-generation solid-state lithium-ion battery materials, aiming to reduce technical risks and accelerate prototype development.

CSL Limited reported a sharp 80% drop in net profit for the half year ended December 2025, driven by significant restructuring and impairment charges, yet maintained its growth guidance and dividend payout.

Electro Optic Systems (EOS) has firmly rejected allegations from a recent Grizzly Research report, highlighting its strengthened financial position, significant contract wins, and strategic acquisition to bolster its defence technology portfolio.

Talga Group has lodged a detailed prospectus for issuing attaching and piggyback options to recent Placement and Share Purchase Plan participants, potentially raising up to A$32.7 million upon exercise. The move supports its battery anode production scale-up and international expansion plans.

TG Metals has lodged a provisional patent application for a new technology that significantly improves lithium recovery and concentrate quality at its Burmeister deposit in Western Australia.

Acusensus Limited has settled its patent litigation with Redflex Traffic Systems, issuing over six million shares and paying US$6 million in cash to resolve the dispute. The agreement clears the way for Acusensus to continue its road safety technology operations unimpeded.

Careteq Limited has agreed to sell its Embedded Health Solutions business for $5 million, aiming to strengthen its balance sheet and focus on expanding its home medication review platform amid ongoing tax disputes.

WRKR Ltd has completed its strategic acquisition of PaidRight Holdings, issuing over 90 million shares to expand its compliance platform into payroll compliance. This move marks a significant step beyond superannuation, aiming to create a comprehensive compliance solution.

Anax Metals is set to release an updated feasibility study for its Whim Creek project, reflecting soaring commodity prices and progressing funding talks to push the project into development.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.